Neuralink’s brain machine interface develops solutions for victims of paralysis, but experts believe it could take several years before the company will receive clearance for commercial use.
Electric carmaker Tesla CEO Elon Musk meets with French Minister for the Economy and Finances Bruno Le Maire on the sidelines of the 6th edition of the"Choose France" Summit at the Chateau de Versailles, outside Paris on May 15, 2023. Following the trial's approval, however, Neuralink shares were marketed privately to investors in recent days at a $7 billion valuation, equivalent to $55 per share, according to an email seen by Reuters.
While Neuralink executives and Musk have not responded to requests for comment, Musk has said the company’s chip would allow healthy and disabled people alike to stop by neighborhood facilities for prompt surgical insertions to treat obesity, autism, depression and schizophrenia. Musk also said he sees them being used for web-surfing and telepathy.
A Neuralink executive recently gave more modest short-term objectives, such as helping paralyzed patients communicate through computerized text without typing.Neuralink's initial request for a human trial was rejected by the FDA last year, citing safety concerns. Since then, Musk’s startup has been scrutinized by U.S. lawmakers after its animal-research board possibly violated conflict-of-interest regulations.
Sverige Senaste nytt, Sverige Rubriker
Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.
Exclusive: Musk's Neuralink valued at about $5 bln despite long road to marketElon Musk's brain implant startup Neuralink, which was valued at close to $2 billion in a private fundraising round two years ago, is now worth around $5 billion based on privately executed stock trades described to Reuters by five sources with knowledge of the matter.
Läs mer »
Musk's Neuralink valued at about $5 billion despite long road to market: Reuters
Läs mer »